Stockscreener 앱 받기
1.71
5.52%
-0.10
시간 외 거래:
1.70
-0.01
-0.58%
전일 마감가:
$1.81
열려 있는:
$1.82
하루 거래량:
836.60K
Relative Volume:
1.58
시가총액:
$168.47M
수익:
$13.56M
순이익/손실:
$-35.57M
주가수익비율:
-3.8444
EPS:
-0.4448
순현금흐름:
$-29.13M
1주 성능:
+31.54%
1개월 성능:
+51.33%
6개월 성능:
+51.33%
1년 성능:
+154.73%
1일 변동 폭
$1.66
$1.8446
1주일 범위
$1.33
$1.935
52주 변동 폭
$0.5327
$2.22
Hyperfine Inc Stock (HYPR) Company Profile
명칭
Hyperfine Inc
전화
866-796-6767
주소
351 NEW WHITFIELD STREET, GUILFORD
Compare HYPR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
1.71 | 178.32M | 13.56M | -35.57M | -29.13M | -0.4448 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | 개시 | Evercore ISI | Outperform |
| 2022-04-14 | 개시 | Wells Fargo | Overweight |
Hyperfine Inc 주식(HYPR)의 최신 뉴스
This Hyperfine analyst begins coverage on a bullish note; here are top 3 initiations for Wednesday - MSN
Short Interest in Hyperfine, Inc. (NASDAQ:HYPR) Drops By 15.3% - MarketBeat
This Hyperfine Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday - Sahm
BTIG initiates Hyperfine stock with buy rating on MRI technology By Investing.com - Investing.com Nigeria
Hyperfine initiated with a Buy at BTIG - TipRanks
Hyperfine (NASDAQ:HYPR) Coverage Initiated by Analysts at BTIG Research - MarketBeat
At India’s top hospital, brain MRI now comes to the bedside - Stock Titan
System Introduced as India’s First Portable MRI for Bedside Brain Imaging at the Country’s Leading Medical Institution - Business Wire
BTIG initiates Hyperfine stock with buy rating on MRI technology - Investing.com
Hyperfine announces AIIMS New Delhi initiated clinical use of Swoop - TipRanks
Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026 - Business Wire
Hyperfine (HYPR) price target increased by 24.24% to 2.09 - MSN
Trend Continuation Check | Hyperfine posts 38.7 pct EPS beat with narrower lossExpert Stock Picks - Cổng thông tin điện tử tỉnh Lào Cai
Hyperfine Inc stock (US44917L1098): Is its portable MRI tech strong enough to unlock medtech upside? - AD HOC NEWS
Hyperfine (HYPR) Stock: Growth Potential Insight (Ticks Lower) 2026-04-20Stock Community Signals - Cổng thông tin điện tử tỉnh Lào Cai
Hyperfine Inc stock (US44917L1098): Is its portable MRI tech strong enough to disrupt diagnostics? - AD HOC NEWS
Hyperfine secures European approvals for next-generation portable MR system - DOTmed
Hyperfine, Inc. (NASDAQ:HYPR) Given Average Rating of "Hold" by Analysts - MarketBeat
Hyperfine Inc stock (US44917L1098): Is portable MRI technology strong enough to unlock new upside? - AD HOC NEWS
Is Hyperfine (HYPR) Stock Testing Resistance | Price at $1.19, Down 2.07%Collaborative Trading Signals - UBND thành phố Hải Phòng
Aug Momentum: Is Hyperfine Inc gaining market shareRate Cut & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Hyperfine receives European approval for portable MRI system By Investing.com - Investing.com India
Aug Opening: Does Hyperfine Inc have a sustainable dividend2026 Snapshot & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Hyperfine, Inc. Receives Ce and Ukca Marks for Next-Generation Swoop System and Latest Advancement in Optive Ai Software - marketscreener.com
Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software - 01net
Hyperfine receives CE Marking, UK Conformity Assessment approval - TipRanks
Hyperfine receives European approval for portable MRI system - Investing.com
Founder‑controlled Hyperfine (HYPR) sets 2026 virtual meeting and pay details - Stock Titan
Head-to-Head Contrast: Hyperfine and Tenon Medical - National Today
What is the future of Hyperfine (HYPR) Stock | Price at $1.13, Up 1.80%Diversification - Cổng thông tin điện tử tỉnh Lào Cai
Institution Moves: Is Blue Bird Corporation stock suitable for long term investing2026 Snapshot & Daily Volume Surge Signals - baoquankhu1.vn
Published on: 2026-04-05 15:20:26 - baoquankhu1.vn
Pullback Watch: Can Hyperfine Inc be recession proofRate Cut & Entry and Exit Point Strategies - baoquankhu1.vn
Hyperfine (HYPR) CFO Brett Hale receives 330,000 RSU equity grant - Stock Titan
Hyperfine (HYPR) COO receives 330,000 RSUs vesting through multi-year period - Stock Titan
Hyperfine (HYPR) CEO receives 750,000 RSU stock award - Stock Titan
Hyperfine (HYPR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga France
Inflation Data: Is Hyperfine Inc affected by consumer sentimentMarket Weekly Review & Daily Price Action Insights - baoquankhu1.vn
Aug Action: Is Hyperfine Inc stock showing strong momentumProfit Target & Long Hold Capital Preservation Plans - baoquankhu1.vn
Hyperfine’s Portable MRI Trial Update Puts Contrast Imaging in the Spotlight - tipranks.com
How Decentralized AI is Unlocking Value in Cardiac Diagnostics - Benzinga
HYPR SEC FilingsHYPERFINE 10-K, 10-Q, 8-K Forms - Stock Titan
Brett Hale Sells 24,188 Shares of Hyperfine (NASDAQ:HYPR) Stock - MarketBeat
Hyperfine COO Teisseyre sells $29k in shares By Investing.com - Investing.com Australia
Hyperfine COO Teisseyre sells $29k in shares - Investing.com
Hyperfine (HYPR) COO sells shares to cover RSU tax obligations - Stock Titan
Hyperfine (HYPR) CFO Brett Hale sells shares to cover RSU tax obligations - Stock Titan
Hyperfine (HYPR) Q4 2025 Earnings Call Transcript - AOL.com
Hyperfine: $40 Million Loan Facility Secured To Expand Portable MRI Commercialization - Pulse 2.0
Hyperfine Inc (HYPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.41%
0.93%
자본화:
|
볼륨(24시간):